Downregulation of VRK1 Inhibits Progression of Lung Squamous Cell Carcinoma through DNA Damage

Table 1

Clinicopathologic characteristics of 25 LUSC patients.

Parameter		Total (n = 25)
Gender	Male	11 (44%)
	Female	14 (66%)
Age (years)	<60	23 (92%)
	≥60	2 (8%)
Tumor size (cm)	<3	20 (80%)
	≥3	5 (20%)
Tumor location	Left	15 (60%)
	Right	10 (40%)
Histological grade	Middle or low	20 (80%)
	High	5 (20%)
Smoking history	Yes	21 (84%)
	No	4 (16%)
Staging	I	8 (32%)
	II	11 (44%)
	III	6 (24%)